Article Type
Changed
Wed, 09/13/2017 - 09:35
Display Headline
In reply: Myasthenia gravis

In Reply: We appreciate Dr. Keiter’s comments. We agree that myasthenia gravis, like most medical disorders, rests on clinical diagnosis. We have patients we treat for myasthenia gravis in the absence of the typical serological confirmation. A very few of these patients with restricted oculobulbar symptoms may also have normal single-fiber EMG studies. In this situation, the decision to treat an individual for myasthenia gravis must rest on the physician’s clinical judgment, but also on the patient’s understanding that the condition does not have the diagnostic support often seen. The decision to treat with medications that have potential severe side effects requires the patient’s understanding of the context in which the diagnosis is being made and the specific treatment is being suggested.

Article PDF
Author and Disclosure Information

Yuebing Li, MD, PhD
Cleveland Clinic

Yeeshu Arora, MD
Cleveland Clinic

Kerry Levin, MD
Cleveland Clinic

Issue
Cleveland Clinic Journal of Medicine - 81(3)
Publications
Topics
Page Number
145-145
Sections
Author and Disclosure Information

Yuebing Li, MD, PhD
Cleveland Clinic

Yeeshu Arora, MD
Cleveland Clinic

Kerry Levin, MD
Cleveland Clinic

Author and Disclosure Information

Yuebing Li, MD, PhD
Cleveland Clinic

Yeeshu Arora, MD
Cleveland Clinic

Kerry Levin, MD
Cleveland Clinic

Article PDF
Article PDF
Related Articles

In Reply: We appreciate Dr. Keiter’s comments. We agree that myasthenia gravis, like most medical disorders, rests on clinical diagnosis. We have patients we treat for myasthenia gravis in the absence of the typical serological confirmation. A very few of these patients with restricted oculobulbar symptoms may also have normal single-fiber EMG studies. In this situation, the decision to treat an individual for myasthenia gravis must rest on the physician’s clinical judgment, but also on the patient’s understanding that the condition does not have the diagnostic support often seen. The decision to treat with medications that have potential severe side effects requires the patient’s understanding of the context in which the diagnosis is being made and the specific treatment is being suggested.

In Reply: We appreciate Dr. Keiter’s comments. We agree that myasthenia gravis, like most medical disorders, rests on clinical diagnosis. We have patients we treat for myasthenia gravis in the absence of the typical serological confirmation. A very few of these patients with restricted oculobulbar symptoms may also have normal single-fiber EMG studies. In this situation, the decision to treat an individual for myasthenia gravis must rest on the physician’s clinical judgment, but also on the patient’s understanding that the condition does not have the diagnostic support often seen. The decision to treat with medications that have potential severe side effects requires the patient’s understanding of the context in which the diagnosis is being made and the specific treatment is being suggested.

Issue
Cleveland Clinic Journal of Medicine - 81(3)
Issue
Cleveland Clinic Journal of Medicine - 81(3)
Page Number
145-145
Page Number
145-145
Publications
Publications
Topics
Article Type
Display Headline
In reply: Myasthenia gravis
Display Headline
In reply: Myasthenia gravis
Sections
Disallow All Ads
Alternative CME
Article PDF Media